Compare Alphabet Inc Class A (GOOGL) vs Novartis AG (NVS) Price & Performance

Alphabet Inc Class ATrade

Novartis AGTrade

Price performance (Past 24H)

Key statistics

Alphabet Inc Class A vs Novartis AG — how do they compare? Alphabet Inc Class A trades at $356 (market cap $4.52T), while Novartis AG trades at $150.91 (market cap $287.66B). The key difference: Alphabet Inc Class A is far larger — about 15.7× Novartis AG's market cap, and Novartis AG pays the higher dividend (3.14%). Which is the better fit depends on your goals.

	GOOGL	NVS
Market Cap	$4.52T	$287.66B
Sector	Media	Health
52-Week High	$402.62	$168.62
52-Week Low	$182.97	$113.50
Enterprise Value	$4.49T	$327.68B
Dividend Yield	0.24%	3.14%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Alphabet Inc Class A

Alphabet (GOOGL) trades at $354.37, down 1.43% on the day, amid a bullish technical setup with strong analyst support. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $5.11 significantly exceeding the $2.64 estimate. Financial health is solid, with 2025 revenue of $402.84 billion and net income of $132.17 billion, reflecting a net margin of 32.8%. Positive news flow highlights AI-driven growth and strategic partnerships.

Outlook remains positive given earnings momentum, AI expansion, and a consensus price target of $431.78 implying 22% upside. Risks include antitrust scrutiny and tech sector volatility. Institutional sentiment is strongly bullish with 85% buy ratings, supporting a favorable risk-reward profile for long-term investors.

Novartis AG

NVS trades at $152.51, up 1.43% today, with a bearish technical signal despite strong profitability metrics including a 75.38% gross margin and 35.21% ROE. Recent earnings show mixed results, missing Q1 2026 estimates but beating Q4 2025. The company is actively expanding its oncology pipeline through acquisitions like Myricx Bio for up to $1.5 billion (Reuters, 2026-07-06).

The outlook is balanced; robust cash flow and high margins support growth, but rising debt-to-asset ratios and cautious analyst consensus (68% hold) indicate near-term headwinds. Key risks include execution of pipeline developments and competitive pressures in pharmaceuticals.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GOOGL

Adams Diversified Equity Fund posts 10.8% NAV return in H1 2026, beating S&P 500's 10.2%.GlobeNewsWire · 4 hours agoBullish Google updates Vids with AI avatars and Gemini Omni for custom video creation.TechCrunch · 6 hours agoBullish Edge AI software market to hit $8.89B by 2031, growing at 24.4% CAGR driven by real-time AI demand.Marketsandmarkets™ · 7 hours agoBullish View details →

NVS

View details →

About Alphabet Inc Class A

Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.